XCUR
XCUR
NASDAQ · Biotechnology

Exicure Inc

$4.10
-0.15 (-3.63%)
As of Apr 1, 3:46 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +651.7% upside
Low Target $21.30
Average Target $30.82
High Target $34.43
Current Price $4.10
Current
$4.10
Target
$30.82
$21.30 $30.82 avg $34.43
Scenario Analysis
Bear Case
$21.30
419.5%
Low target
Base Case
$30.82
+651.7%
Avg target
Bull Case
$34.43
+739.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$14.73
-72.2% from high
52-Week Low
$3.10
+32.2% from low
Target vs 52W High
$30.82
+109.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%